Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002100119-26-000204
Filing Date
2026-04-29
Accepted
2026-04-29 16:59:32
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5663
  Complete submission text file 0002100119-26-000204.txt   7591
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Subject) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-38985 | Film No.: 26917588
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 100 VANGUARD BLVD MALVERN PA 19355
Business Address 100 VANGUARD BLVD MALVERN PA 19355 610-669-6148
VANGUARD CAPITAL MANAGEMENT LLC (Filed by) CIK: 0002100119 (see all company filings)

EIN.: 392877419 | State of Incorp.: PA | Fiscal Year End: 1231
LEI: 529900ZEWTRLEJ6XE960
Type: SCHEDULE 13G